Global Medtech Contract Development and Manufacturing Market H1 2026 M&A Update
Learn about the H1 2026 M&A trends in the medtech CDMO market including deal activity, geographic distribution of transactions, and target end-markets.
Key Life Sciences Insights
Our team of scientists, strategists, economists, clinicians, and biostatisticians stay on the cutting edge of the evolving landscape. We collect their insights and the latest thinking and invite you to explore these resources.
Key Life Sciences Insights
Our team of scientists, strategists, economists, clinicians, and biostatisticians stay on the cutting edge of the evolving landscape. We collect their insights and the latest thinking and invite you to explore these resources.
Featured Publication
The 2026 Edition of Our Signature Biologics Contract Manufacturing Report Is Now Out!
Access the latest edition of our signature report to explore how specialized manufacturing capabilities, investment, and M&A are reshaping the global biologics contract manufacturing landscape.
Alira Health Market Intelligence
Access our latest reports and white papers, featuring insights across multiple healthcare markets, including pharma, medtech, and more.
The 2026 Biologics Contract Manufacturing Report
Discover the latest biologics CDMO market insights on manufacturing, investment, and M&A trends shaping the industry. Access the 2026 report today.
Nuclear Medicine in 2026: How Market Access Determines Lifecycle Success
Discover how nuclear medicine market access shapes lifecycle success in 2026 and what leaders must do to align strategy, evidence, and delivery.
Explore our Success Stories
Discover how we help our clients solve complex challenges. Explore our collection of case studies to learn more about our approach.
Infection Control and Prevention Company Defines Winning US Market Entry Strategy
Discover how an infection prevention company defined a successful US market entry strategy amid regulatory uncertainty for novel wound care disinfectant products.
Small Biotech Company With Complex, Innovative Cell Immunotherapy in Oncology Executes Successful Phase Ib Clinical Trial Across Multiple Sites
Discover how a biotech company executed a complex Phase I trial with Alira Health, ensuring seamless coordination of manufacturing, logistics, and sites.
European Biotech Company Implements a Quality Management System Tailored for Agile SaaS Development
Discover how a biotech SaaS company implemented an ISO 13485 and IEC 62304 compliant QMS tailored to an agile development.
Expert Interviews
Discover expert interviews featuring thought leadership and practical insights from Alira Health specialists.
Rare Disease Trial Recruitment: The Role of Patient Registries
Explore how registries in rare disease trial recruitment connect sponsors with patient communities to improve identification and enrollment.
Clinical Trial Excellence in 2026: Managing the Complexity of Modern Clinical Development
Learn what clinical trial excellence means in complex product development and how biotech leaders can manage new complexity, risk, and executional pressure.
From Approval to Adoption: A New Framework for Medtech Success
Medtech success requires more than approval. Discover how aligning evidence, patient needs, and market access drives adoption.
Articles
Read our articles that provide insight to those innovating and developing in multiple healthcare markets, including pharma, medtech and more.
Patient Preference Studies: Patient Experience as Decision-Grade Evidence
Discover how patient preference studies use qualitative and quantitative methods to generate decision-Grade Evidence across development and commercialization.
FDA Initiatives and Programs to Support Development of Treatments for Rare Diseases in 2026
Discover FDA programs in 2026 that foster rare disease drug development, offering guidance, funding, and regulatory support for innovators.
How to Develop Global Clinical Evidence Strategies for Regulatory Success in Medtech
Discover how a strategically planned clinical evidence generation strategy can support global device approval, maximize evidence value, and prepare for international expansion.
Webinars
Listen to the latest insights from Alira Health experts featured in webinars. Just hit play!
Cross-Border Access to Rare Disease Clinical Trials: A Patient-Centric Approach to Feasibility and Execution
Watch the webinar to get practical insights on cross-border rare disease clinical trials and explore patient-centric strategies that support sponsor execution and patient access.
Global Payer Forum 2026
Educational webinar series about Value-Based Contracting by payers and academic experts and covering VBC fundamentals to success assessment.
Most Favored Nation: US Implementation and European Implications
This webinar explores how MFN pricing may impact US drug prices, access in Europe, launch strategies, and biotech investment.